Cite
HARVARD Citation
Wynne, C. et al. (2020). Immunogenicity and safety of a proposed pegfilgrastim biosimilar MSB11455 versus the reference pegfilgrastim Neulasta® in healthy subjects: A randomized, double‐blind trial. Pharmacology research & perspectives. 8 (2), p. n/a. [Online].